Catalyst Wire Dossier Catalyst Wire Dossier

recombinant human CD4-immunoglobulin G (rCD4-IgG)

recombinant human CD4-immunoglobulin G
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for recombinant human CD4-immunoglobulin G (rCD4-IgG), covering 2008-08-06 to 2008-08-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex [Phase 1]

See pricing